Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Socs2
REST API REST API
Rattus norvegicus
Socs2 is differentially expressed in 61 experiments: 32 organism parts: hippocampus, kidney, ... (30 more);, 3 disease states: breast carcinoma, moderate spinal cord injury, ... (1 more);, 8 cell types 8 compound treatments 2 biosource types and 13 other conditions.
Synonyms Cish2, Socs-2
Orthologs Q4H2S6_CIOIN (Ciona intestinalis)   Q8AYA6_CHICK (Gallus gallus)   socs2 (Danio rerio)   Gm9847 (Mus musculus)   SOCS2 (Homo sapiens)   Socs2 (Mus musculus)   socs2 (Xenopus laevis)   (Compare orthologs)
InterPro Term SH2, SOCS_C
Gene Ontology Term insulin-like growth factor receptor binding, protein binding, negative regulation of signal transduction, molecular_function, aging, cellular_component, regulation of growth, response to peptide hormone stimulus, growth hormone receptor signaling pathway, response to estradiol stimulus, cellular response to hormone stimulus, intracellular signal transduction
UniProt Accession O88582, Q9QX77
Search EB-eye ENSRNOG00000008965
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-19830, E-GEOD-2354, E-AFMX-7, E-GEOD-142, E-GEOD-2852, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-GEOD-2499, E-TABM-130, E-GEOD-2032, E-TABM-432

Factor Value U/D Experiments
Sertoli cell
2
1
E-TABM-432
myoctye
1
E-GEOD-2032
1
E-TABM-130
spermatid
1
E-TABM-130
spermatogonium
1
E-TABM-432
multipotent neural progenitor cell
1
E-GEOD-2499
2 more value(s).


Disease state

studied in E-GEOD-1872, E-GEOD-464

Factor Value U/D Experiments
moderate spinal cord injury
1
1
E-GEOD-464
breast carcinoma
1
E-GEOD-1872
normal
27
1
E-GEOD-1872


Compound treatment

studied in E-MEXP-1421, E-MEXP-1169, E-GEOD-4028, E-GEOD-22647

Factor Value U/D Experiments
furan
1
E-MEXP-1421
forskolin
1
1
E-MEXP-1169
vehicle
1
E-GEOD-22647
none
1
E-MEXP-1421
control
9
1
E-GEOD-4028
diethylstilbestrol
1
E-GEOD-4028
2 more value(s).


Biosource type

studied in E-MEXP-1069

Factor Value U/D Experiments
frozen_sample
1
E-MEXP-1069
fresh_sample
1
E-MEXP-1069


Clinical treatment

studied in E-GEOD-7002, E-GEOD-738, E-GEOD-1616

Factor Value U/D Experiments
trigger of ischemic preconditioning
1
E-GEOD-1616
instillation
1
E-GEOD-7002
none
4
1
E-GEOD-738
inhalation
1
E-GEOD-7002


Cohort
studied in E-GEOD-20388

Developmental stage
studied in E-GEOD-4236, E-MEXP-570, E-GEOD-20245

Genetic modification
studied in E-GEOD-6428

Growth condition
studied in E-GEOD-7041, E-MEXP-2863

Material type
studied in E-GEOD-467

protocol
studied in E-GEOD-20895

Protocol type
studied in E-MEXP-1421, E-GEOD-1139, E-GEOD-1616, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-TABM-197, E-MTAB-322, E-TABM-457, E-AFMX-7, E-MTAB-323, ... (7 experiments)

Temperature
studied in E-MEXP-1069

tissue region
studied in E-GEOD-21681

Treatment
studied in E-GEOD-19909

Processing time: 0.686 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM